Marieke Vermeersch
Marieke Vermeersch has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Heng Jiang
Department of Radiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
3 shared publications - Mark De Ridder
Department of Radiotherapy, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium
3 shared publications - Dirk Verellen
Department of Radiation Oncology, Iridium Network, Wilrijk (Antwerp), Belgium; Integrated Personalised and Precision Oncology Network, University Antwerp, Antwerp, Belgium
2 shared publications - Ka Lun Law
VUB (free University Brussels), Jette, Belgium
2 shared publications - Louis Maes
Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Infla-Med Centre of Excellence, University of Antwerp, Wilrijk, Belgium
2 shared publications - Paul Cos
Laboratory for Microbiology, Parasitology and Hygiene (LMPH), Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp, Belgium
2 shared publications
Latest Publications
- Open Access
- 6 August 2025
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 20 (1)
Fast track to environmentally adapted rhizobia for growing soybean at northern latitudes using citizen science
Soybean serves as a crucial source of plant-based protein for human diets. Recently, there is a growing incentive to extend the range of this crop to more northern latitudes, in order to enable profitable soybean production in Europe. To reach economic yields, soybean requires inoculation with symbiotic, diazotrophic rhizobial bacteria. However, the performance of commercial inocula is often variable under local conditions. Here, we present the citizen science project “Soy in 1,000 Gardens”, a large-scale trapping experiment for isolating local soybean-nodulating rhizobia in Flanders, Belgium. We identified two locally isolated Bradyrhizobium strains performing at least as well as commercial strain B. diazoefficiens G49 in local field trials. Additionally, we found that nutrient content, microbial alpha diversity, and the presence of arbuscular mycorrhizal fungi in the soil were correlated with nodulation. Finally, we report a correlation between low bacterial alpha diversity and red nodule interior, and identified Tardiphaga as a dominant colonizer of red nodules.
- 6 August 2025
- Published by Oxford University Press (OUP) in The ISME Journal
- Vol. 20 (1)
Open AccessFast track to environmentally adapted rhizobia for growing soybean at northern latitudes using citizen science
Soybean serves as a crucial source of plant-based protein for human diets. Recently, there is a growing incentive to extend the range of this crop to more northern latitudes, in order to enable profitable soybean production in Europe. To reach economic yields, soybean requires inoculation with symbiotic, diazotrophic rhizobial bacteria. However, the performance of commercial inocula is often variable under local conditions. Here, we present the citizen science project “Soy in 1,000 Gardens”, a large-scale trapping experiment for isolating local soybean-nodulating rhizobia in Flanders, Belgium. We identified two locally isolated Bradyrhizobium strains performing at least as well as commercial strain B. diazoefficiens G49 in local field trials. Additionally, we found that nutrient content, microbial alpha diversity, and the presence of arbuscular mycorrhizal fungi in the soil were correlated with nodulation. Finally, we report a correlation between low bacterial alpha diversity and red nodule interior, and identified Tardiphaga as a dominant colonizer of red nodules.
- 15 April 2013
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 73 (8_Suppleme) , 4986
Abstract 4986: Myeloid-derived suppressor cells as a biomarker of tumor growth and radiosensitivity: Role of hypoxia-inducible arginase-1.
Introduction: Recent evidence suggests that tumor growth and metastases are sustained by myeloid-derived suppressor cells (MDSC), which over-express arginase-1 (ARG) and cause T-cell suppression. We hypothesize that MDSC impair tumor cell radiosensitivity through ARG-mediated depletion of L-arginine, an essential substrate for the biosynthesis of the endogenous radiosensitizer nitric oxide (NO). Aim: We explored whether MDSC and ARG can be used as biomarkers for tumor growth in experimental mouse models and in the clinical setting of colorectal cancer (CRC). We further examined whether low L-arginine levels are associated with an impaired generation of NO by inducible NO synthase (iNOS) and a reduced radiosensitivity of hypoxic tumor cells. Materials & methods: MDSC (CD11b+Gr-1+) and ARG levels in mouse colon CT26 and mammary 4T1 models were analyzed by flow cytometry (FCM) and RT-PCR. Mice were inoculated I.M. with either CT26 or 4T1 carcinoma cells. After 17 days, MDSC were quantified in the spleen by FCM. In addition, ARG levels were analyzed by RT-PCR and FCM. Similar analyses were performed on human blood MDSC (CD14+HLA-DRlow) derived from CRC patients. To model the hypoxic tumor microenvironment, mouse splenocytes were cultured in 1% oxygen. Activation of iNOS was induced by LPS/IFN-γ and analysed by RT-PCR, Western blot and Griess assay. Radiosensitivity was analysed in a model of metabolic hypoxia by colony formation assay Results: The growth of both CT26 and 4T1 tumors in BALB/c mice was associated with an accumulation of MDSC in the spleen from 2-4% (in naive mice) to 8 and 35% respectively. Freshly isolated splenocytes and MDSC showed low ARG levels. Contrasting, hypoxia-conditioned splenocytes from tumor-bearing mice revealed a drastic transcriptional activation of ARG (up to 525.000-fold), and ARG+ MDSC. On the other hand splenocytes from tumor-free mice did not display ARG activation in hypoxic conditions. The iNOS/NO-mediated radiosensitization of mammary EMT6 tumor cells was strictly dependent on L-arginine levels, with a marginal effect of 1.2-fold at 10-30 μM while approaching a 2.4-fold effect at a physiological concentration of 125 μM. MDSC levels in CRC patients were increased, as compared with healthy donors (8-12% versus 4-5%). Patients with locally advanced CRC had 16-fold higher ARG expression in blood monocytes, as compared to healthy donors. 4 weeks after pre-operative radiotherapy the ARG levels decreased by 2-fold. Conclusions: Although tumor progression is clearly associated with the expansion of MDSC, their hypoxic conditioning appears to be crucial to uncover ARG as a tumor biomarker in vivo. iNOS/NO mediated radiosensitisation of hypoxic tumor cells was drastically impaired at low L-arginine levels which could be depleted by ARG+ MDSC. In a clinical setting, we consider ARG a potential biomarker in locally advanced rectal cancer. Citation Format: Wim Leonard, Inès Dufait, Heng Jiang, Femke Steenbeke, Marieke Vermeersch, Kalun Law, Guy Storme, Joeri Aerts, Valeri Verovski, Mark De Ridder. Myeloid-derived suppressor cells as a biomarker of tumor growth and radiosensitivity: Role of hypoxia-inducible arginase-1. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4986. doi:10.1158/1538-7445.AM2013-4986
- 15 April 2013
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 73 (8_Suppleme) , 4986
Abstract 4986: Myeloid-derived suppressor cells as a biomarker of tumor growth and radiosensitivity: Role of hypoxia-inducible arginase-1.
Introduction: Recent evidence suggests that tumor growth and metastases are sustained by myeloid-derived suppressor cells (MDSC), which over-express arginase-1 (ARG) and cause T-cell suppression. We hypothesize that MDSC impair tumor cell radiosensitivity through ARG-mediated depletion of L-arginine, an essential substrate for the biosynthesis of the endogenous radiosensitizer nitric oxide (NO). Aim: We explored whether MDSC and ARG can be used as biomarkers for tumor growth in experimental mouse models and in the clinical setting of colorectal cancer (CRC). We further examined whether low L-arginine levels are associated with an impaired generation of NO by inducible NO synthase (iNOS) and a reduced radiosensitivity of hypoxic tumor cells. Materials & methods: MDSC (CD11b+Gr-1+) and ARG levels in mouse colon CT26 and mammary 4T1 models were analyzed by flow cytometry (FCM) and RT-PCR. Mice were inoculated I.M. with either CT26 or 4T1 carcinoma cells. After 17 days, MDSC were quantified in the spleen by FCM. In addition, ARG levels were analyzed by RT-PCR and FCM. Similar analyses were performed on human blood MDSC (CD14+HLA-DRlow) derived from CRC patients. To model the hypoxic tumor microenvironment, mouse splenocytes were cultured in 1% oxygen. Activation of iNOS was induced by LPS/IFN-γ and analysed by RT-PCR, Western blot and Griess assay. Radiosensitivity was analysed in a model of metabolic hypoxia by colony formation assay Results: The growth of both CT26 and 4T1 tumors in BALB/c mice was associated with an accumulation of MDSC in the spleen from 2-4% (in naive mice) to 8 and 35% respectively. Freshly isolated splenocytes and MDSC showed low ARG levels. Contrasting, hypoxia-conditioned splenocytes from tumor-bearing mice revealed a drastic transcriptional activation of ARG (up to 525.000-fold), and ARG+ MDSC. On the other hand splenocytes from tumor-free mice did not display ARG activation in hypoxic conditions. The iNOS/NO-mediated radiosensitization of mammary EMT6 tumor cells was strictly dependent on L-arginine levels, with a marginal effect of 1.2-fold at 10-30 μM while approaching a 2.4-fold effect at a physiological concentration of 125 μM. MDSC levels in CRC patients were increased, as compared with healthy donors (8-12% versus 4-5%). Patients with locally advanced CRC had 16-fold higher ARG expression in blood monocytes, as compared to healthy donors. 4 weeks after pre-operative radiotherapy the ARG levels decreased by 2-fold. Conclusions: Although tumor progression is clearly associated with the expansion of MDSC, their hypoxic conditioning appears to be crucial to uncover ARG as a tumor biomarker in vivo. iNOS/NO mediated radiosensitisation of hypoxic tumor cells was drastically impaired at low L-arginine levels which could be depleted by ARG+ MDSC. In a clinical setting, we consider ARG a potential biomarker in locally advanced rectal cancer. Citation Format: Wim Leonard, Inès Dufait, Heng Jiang, Femke Steenbeke, Marieke Vermeersch, Kalun Law, Guy Storme, Joeri Aerts, Valeri Verovski, Mark De Ridder. Myeloid-derived suppressor cells as a biomarker of tumor growth and radiosensitivity: Role of hypoxia-inducible arginase-1. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4986. doi:10.1158/1538-7445.AM2013-4986
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S155
OC-0386 NITRIC OXIDE-PRODUCING HEPATOCYTES RADIOSENSITIZE HYPOXIC COLORECTAL CANCER CELLS THROUGH OXYGEN SPARING
- 1 May 2012
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 103, S155
OC-0386 NITRIC OXIDE-PRODUCING HEPATOCYTES RADIOSENSITIZE HYPOXIC COLORECTAL CANCER CELLS THROUGH OXYGEN SPARING
- 15 April 2012
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (8_Suppleme) , 1474
Abstract 1474: Hepatocytes either radioprotect or sensitize colorectal cancer cells through nitric oxide-induced oxygen sparing in hypoxic microenvironment
Purpose: Impaired tumor oxygenation remains a major obstacle to curative radiotherapy in advanced primary tumors and metastases. In this study, tailored to the liver metastases of colorectal cancer (CRC), we compared the ability of tumor cells and normal host hepatocytes to metabolically consume oxygen and induce hypoxia. Next, we examined the possibility to re-oxygenate and thereby radiosensitize human CRC cells through the physiological mediator nitric oxide (NO) that switches the mitochondrial oxygen metabolism in hepatocytes from consumption to sparing. Methods and Materials: To model tumor-relevant hypoxia, hepatocytes and tumor cells were incubated in a tissue-mimetic co-culture system with limited oxygenation, which was monitored by fluorescence and linked to hypoxic radioresponse. To activate NO production through inducible nitric oxide synthase (iNOS), hepatocytes (or tumor cells) were exposed to a cytokine mixture of IFN-γ, TNF-α, IL-1α and LPS, and iNOS expression was examined by RT-PCR, western blotting, and NO/nitrite production. Results: Primary mouse hepatocytes consumed 10 to 40-times more oxygen than mouse CT26 and human DLD-1, HT29, HCT116 and SW480 CRC cells, suggesting that hepatocytes are the major effectors of hypoxic conditioning. At cell densities of 0.6-1.2 mln/ml, hepatocytes induced radiobiologically-relevant hypoxia within 20 min, and thereby radioprotected tumor cells 2.0 to 2.5-times. Following exposure to cytokines, hepatocytes revealed significant activation of iNOS-mediated production of NO that targeted mitochondrial aconitase and complexes II, and induced a profound respiratory self-arrest at up to 90 min. As a result, the spared oxygen caused uniform re-oxygenation and radiosensitization in a panel of CRC cell lines (by 1.9 to 2.7-times). Next, both oxygen sparing and radiosensitization could be counteracted by aminoguanidine, a metabolic iNOS inhibitor. Contrasting, all CRC cell lines showed little if any iNOS expression and therefore could not contribute to the oxygen-sparing and radiosensitizing effects of NO-producing hepatocytes. Finally, the NO donor S-nitroso-N-acetylpenicillamine and the mitochondrial inhibitors rotenone, antimycine A and sodium azide were able to block the mitochondrial respiratory chain and to reverse both metabolic hypoxia and hypoxia-induced radioresistance. Conclusion: Hepatocytes may profoundly modulate the hypoxic microenvironment and either protect or sensitize CRC cells to radiation, dependent on the mitochondrial respiratory switch. Our study for the first time provides evidence that host liver cells possess intrinsic radiosensitizing potential through NO-induced oxygen sparing. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1474. doi:1538-7445.AM2012-1474
- 15 April 2012
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (8_Suppleme) , 1474
Abstract 1474: Hepatocytes either radioprotect or sensitize colorectal cancer cells through nitric oxide-induced oxygen sparing in hypoxic microenvironment
Purpose: Impaired tumor oxygenation remains a major obstacle to curative radiotherapy in advanced primary tumors and metastases. In this study, tailored to the liver metastases of colorectal cancer (CRC), we compared the ability of tumor cells and normal host hepatocytes to metabolically consume oxygen and induce hypoxia. Next, we examined the possibility to re-oxygenate and thereby radiosensitize human CRC cells through the physiological mediator nitric oxide (NO) that switches the mitochondrial oxygen metabolism in hepatocytes from consumption to sparing. Methods and Materials: To model tumor-relevant hypoxia, hepatocytes and tumor cells were incubated in a tissue-mimetic co-culture system with limited oxygenation, which was monitored by fluorescence and linked to hypoxic radioresponse. To activate NO production through inducible nitric oxide synthase (iNOS), hepatocytes (or tumor cells) were exposed to a cytokine mixture of IFN-γ, TNF-α, IL-1α and LPS, and iNOS expression was examined by RT-PCR, western blotting, and NO/nitrite production. Results: Primary mouse hepatocytes consumed 10 to 40-times more oxygen than mouse CT26 and human DLD-1, HT29, HCT116 and SW480 CRC cells, suggesting that hepatocytes are the major effectors of hypoxic conditioning. At cell densities of 0.6-1.2 mln/ml, hepatocytes induced radiobiologically-relevant hypoxia within 20 min, and thereby radioprotected tumor cells 2.0 to 2.5-times. Following exposure to cytokines, hepatocytes revealed significant activation of iNOS-mediated production of NO that targeted mitochondrial aconitase and complexes II, and induced a profound respiratory self-arrest at up to 90 min. As a result, the spared oxygen caused uniform re-oxygenation and radiosensitization in a panel of CRC cell lines (by 1.9 to 2.7-times). Next, both oxygen sparing and radiosensitization could be counteracted by aminoguanidine, a metabolic iNOS inhibitor. Contrasting, all CRC cell lines showed little if any iNOS expression and therefore could not contribute to the oxygen-sparing and radiosensitizing effects of NO-producing hepatocytes. Finally, the NO donor S-nitroso-N-acetylpenicillamine and the mitochondrial inhibitors rotenone, antimycine A and sodium azide were able to block the mitochondrial respiratory chain and to reverse both metabolic hypoxia and hypoxia-induced radioresistance. Conclusion: Hepatocytes may profoundly modulate the hypoxic microenvironment and either protect or sensitize CRC cells to radiation, dependent on the mitochondrial respiratory switch. Our study for the first time provides evidence that host liver cells possess intrinsic radiosensitizing potential through NO-induced oxygen sparing. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1474. doi:1538-7445.AM2012-1474
- 1 July 2008
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 74 (09) , PA143
Induction of apoptosis by the triterpene saponin PX-6518 in promastigotes and amastigotes of Leishmania infantum
Aim: Current first-line medication of visceral leishmaniasis is increasingly faced with levels of resistance and therefore new drugs are still needed [1]. The 13,28 epoxy-oleanane saponin PX-6518 showed strong antileishmania properties in vivo [2]. Because little is known about its mode-of-action, the induction of apoptosis was studied on promastigotes and extracellular and intracellular amastigotes of L. infantum. Miltefosin, for which apoptosis-inducing action was already demonstrated [3], was used as reference. Methods: Early apoptosis, characterized by phosphatidylserine (PS) exposure from the inner to the outer side of the cell membrane, was evaluated by Annexin V-FITC/PI labeling (Ann/PI) in treated promastigotes and extracellular amastigotes. Differential sensitivities of axenically grown and fresh ex vivo amastigotes were compared. Microscopic and flow cytometric follow-up studies included DNA fragmentation in oligonucleosomal fragments using a Tunel assay. The effects on intracellular amastigotes were studied in J774 and primary peritoneal macrophages. Results: Ann/PI evaluation of PX-6518 treated host cells demonstrated signs of apoptosis induction, whereas treatment of promastigotes and axenic amastigotes did not induce PS exposure. Evaluation of ex vivo amastigotes was hampered by the fact that a large proportion of untreated control cells were Ann-positive and PI-negative. This result confirms earlier reports of apoptotic mimicry [4]. No additional effects of PX-6518 could be observed in the small fraction of Ann+, PI- amastigotes. These initial observations are now studied in greater detail using the Tunel assay. Conclusion: Features of early apoptosis were observed after treatment of macrophages with PX-6518. The effects on promastigotes and extracellular amastigotes were marginal. References: 1. Croft S. et al. (2003) Trends Parasitol 19: 502–508 2. Maes L. et al. (2004) Antimicrob Agents Chemother 48: 2056–2060 3. Sudhandiran G. et al. (2003)J Biol Chem 278: 25120–25132 4. Wanderley J. et al. (2006)J Immunol 176: 1834–1839.
- 1 July 2008
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 74 (09) , PA143
Induction of apoptosis by the triterpene saponin PX-6518 in promastigotes and amastigotes of Leishmania infantum
Aim: Current first-line medication of visceral leishmaniasis is increasingly faced with levels of resistance and therefore new drugs are still needed [1]. The 13,28 epoxy-oleanane saponin PX-6518 showed strong antileishmania properties in vivo [2]. Because little is known about its mode-of-action, the induction of apoptosis was studied on promastigotes and extracellular and intracellular amastigotes of L. infantum. Miltefosin, for which apoptosis-inducing action was already demonstrated [3], was used as reference. Methods: Early apoptosis, characterized by phosphatidylserine (PS) exposure from the inner to the outer side of the cell membrane, was evaluated by Annexin V-FITC/PI labeling (Ann/PI) in treated promastigotes and extracellular amastigotes. Differential sensitivities of axenically grown and fresh ex vivo amastigotes were compared. Microscopic and flow cytometric follow-up studies included DNA fragmentation in oligonucleosomal fragments using a Tunel assay. The effects on intracellular amastigotes were studied in J774 and primary peritoneal macrophages. Results: Ann/PI evaluation of PX-6518 treated host cells demonstrated signs of apoptosis induction, whereas treatment of promastigotes and axenic amastigotes did not induce PS exposure. Evaluation of ex vivo amastigotes was hampered by the fact that a large proportion of untreated control cells were Ann-positive and PI-negative. This result confirms earlier reports of apoptotic mimicry [4]. No additional effects of PX-6518 could be observed in the small fraction of Ann+, PI- amastigotes. These initial observations are now studied in greater detail using the Tunel assay. Conclusion: Features of early apoptosis were observed after treatment of macrophages with PX-6518. The effects on promastigotes and extracellular amastigotes were marginal. References: 1. Croft S. et al. (2003) Trends Parasitol 19: 502–508 2. Maes L. et al. (2004) Antimicrob Agents Chemother 48: 2056–2060 3. Sudhandiran G. et al. (2003)J Biol Chem 278: 25120–25132 4. Wanderley J. et al. (2006)J Immunol 176: 1834–1839.
- 24 August 2006
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 72 (11) , S_028
Structure-activity-relationship (SAR) for in vitro antileishmanial activity of maesabalide (PX-6518) analogue natural products
Maesabalides (PX-6518) were isolated from the leaves of Maesa balansae Mez. (Myrsinaceae) and shown to have a strong and selective in vitro and in vivo action against the intracellular protozoan Leishmania [1, 2]. Efforts to establish a SAR by selective chemical derivatisation have been hampered by the complexity of the maesabalide moiety [3]. As an alternative approach exploiting available natural diversity, a literature search for structural analogues was performed based on the sapogenin core, i.e. the triterpenoid skeleton with the presence of the hemi-acetal moiety between C-13 and C-17. The search produced >200 molecules belonging to a several plant genera: Aegicerus, Atroxima, Anagallis, Anamirta, Androsace, Ardisia, Burseria, Cyclamen, Eleutherococcus, Eucommia, Euptelea, Grindelia, Leucas, Lysimachia, Myrsine, Platycodon, Primula, Polemonium and Thevetia. None of these were ever evaluated for antileishmanial activity. The activity against intracellular amastigotes of L.donovani could be determined for some Ardisia (IC50=10µg/mL), Maesa (IC50=Lysimachia (IC50=11µg/mL), Anagallis (IC50=Primula (IC50=14µg/mL) species. The IC50-values for the measabalide PX-6518 was 0.06µg/mL and for the reference drug Miltefosin 8µM. The fact that several active 'hits' were identified confirms that specific derivatives do indeed retain antileishmania activity. However, the occurrence of several negatives also shows that the active maesabalide moiety cannot be subject for major structural changes, endorsing its unique potential. Structural factors that may affect the pharmacological activity will be discussed, but more of the above listed plant genera should be investigated to establish a more complete SAR. Acknowledgements: WHO-TDR (Geneva, Switserland), DGOS (Brussels, Belgium), Tibotec (Mechelen, Belgium) References: 1. Maes, L., et al. (2004), Antimicrob. Agents & Chemotherap. 48: 130–136. 2. Maes, L., et al. (2004), Antimicrob. Agents & Chemotherap. 48: 2056–2060. 3. Germonprez, N., et al. (2005), J. Med. Chem, 48: 32–37.
- 24 August 2006
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 72 (11) , S_028
Structure-activity-relationship (SAR) for in vitro antileishmanial activity of maesabalide (PX-6518) analogue natural products
Maesabalides (PX-6518) were isolated from the leaves of Maesa balansae Mez. (Myrsinaceae) and shown to have a strong and selective in vitro and in vivo action against the intracellular protozoan Leishmania [1, 2]. Efforts to establish a SAR by selective chemical derivatisation have been hampered by the complexity of the maesabalide moiety [3]. As an alternative approach exploiting available natural diversity, a literature search for structural analogues was performed based on the sapogenin core, i.e. the triterpenoid skeleton with the presence of the hemi-acetal moiety between C-13 and C-17. The search produced >200 molecules belonging to a several plant genera: Aegicerus, Atroxima, Anagallis, Anamirta, Androsace, Ardisia, Burseria, Cyclamen, Eleutherococcus, Eucommia, Euptelea, Grindelia, Leucas, Lysimachia, Myrsine, Platycodon, Primula, Polemonium and Thevetia. None of these were ever evaluated for antileishmanial activity. The activity against intracellular amastigotes of L.donovani could be determined for some Ardisia (IC50=10µg/mL), Maesa (IC50=Lysimachia (IC50=11µg/mL), Anagallis (IC50=Primula (IC50=14µg/mL) species. The IC50-values for the measabalide PX-6518 was 0.06µg/mL and for the reference drug Miltefosin 8µM. The fact that several active 'hits' were identified confirms that specific derivatives do indeed retain antileishmania activity. However, the occurrence of several negatives also shows that the active maesabalide moiety cannot be subject for major structural changes, endorsing its unique potential. Structural factors that may affect the pharmacological activity will be discussed, but more of the above listed plant genera should be investigated to establish a more complete SAR. Acknowledgements: WHO-TDR (Geneva, Switserland), DGOS (Brussels, Belgium), Tibotec (Mechelen, Belgium) References: 1. Maes, L., et al. (2004), Antimicrob. Agents & Chemotherap. 48: 130–136. 2. Maes, L., et al. (2004), Antimicrob. Agents & Chemotherap. 48: 2056–2060. 3. Germonprez, N., et al. (2005), J. Med. Chem, 48: 32–37.